A Decisive BounceA decisive bounce off support line will herald a continuation of the uptrend.Longby Tahawe4
Intuitive Surgical: expensive and to exit consolidationIntuitive Surgical produces robotic-assisted surgical systems. Currently, the company holds a significant market share in urology and gynecology areas. However, the business model is predicted to expand to other areas such as thoracic, colorectal, and other general soft tissue procedures. From a technical point of view, the stock recovered the highs registered in April 2019, retracing on the last day of trading to the $581 level. However, the price was not able to overtake the $600 resistance that I consider essential in that case. The last session closed above the green Ichimoku Cloud; however, I see the price too close to the cloud support at $572.71. An important signal comes from the Chikou Span (Lagging Span) of the Ichimoku Clouds. The "lagging span" is created by plotting closing prices 26 periods behind the latest closing price of an asset. Usually, when the price is above the line, it could be an indication of weakness (price too high). On the other hand, when the price is below the Chikou span, it could be an indication of strength (price too low). I highlighted in the graph the relationship between the Chikou Span and the current price. The last close perfectly matched the Lagging Span price. Besides, I believe that the market overvalues the company. The stock is currently trading above its normal Price/EBITDA ratio of 32.75, at 50.13 (I used ten years of data). Probably the stock is too expensive. My strategy is to wait until the green support of the green cloud (orange in the chart) is broken. To be sure of the beginning of a downtrend, however, wait until the red support of the green cloud is overtaken (purple in the chart). Disclosure: My articles contain statements and projections based on assumptions on capital markets, and therefore inherently subject to numerous risks and uncertainties. Before buying or selling any stock you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal. I am not a financial advisor. Shortby Investing_Fellow3
$ISRG | Weekly TF | Trend is your frienddnt fight the trend, eyes open, watch for a breakout, manage risk and use stops, look for good risk:reward set-upsLongby WafflesDxb5
ISRG Long to $586Nice candle yesterday + today, chart looks good, stoch + RSILongby LittleCashUpdated 224
Looks like its readyThis one can be tricky but Im thinking its getting ready if it can breakout then 590-600c for next week small sizeby Option_Traders6
Intuitive Surgical trade setup. Entry level $ 592 = Target price $643 = Stop loss $578 technically and fundamental bullish with great momentum in the stock, RSI has plenty of upside. Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.Longby Bullishcharts29
Stock of the week: ISRG ready to advance!Check out the stock of the week! ISRG Completed Re-Accumulation Trading Range and starts to outperform LONG SETUP Pattern Confirmation: Rally above $600 Pattern Failure: Close below $475 Trading Target : $510 count line + (29 boxes*3 reversal* $5 box size)=$895 Happy trading, RomanLongby Wyckoff_Analytics2210
Buy $ISRG - 1D TFI am long in $ISRG and have opened buy position. 1D MA50 has crossed MA200 and I am expecting the range to be broken to the upside. 1D DC20 has been broken on 18th October. With checking the weekly outlook after a year of ranging this may now be the time for the uptrend to continue. SL can be triggered if daily candle closes below MA50, MA200 and DC20. I have no defined TP at this stage - either going for trailing stop or monitoring indicators (e.g. heavily oversold RSI condition, Stoch RSI and locking profits accordingly if the market goes in favor. Any comments are more than welcomed! Thank you and please trade carefully and with money you can afford to lose. To prove real trade stats please do not hesitate to check eToro - www.etoro.com Longby drgorogbalazsUpdated 5
ISRG Looks long to me.I like the monthly (almost complete), weekly and daily charts. I really like the weekly look. Gap filled on Daily too.Longby cghursh1
ISRG before EarningsExpecting a breakout to higher grounds (560+), all indications check out positively for ER today after close . Lines and connections have been averaged on the 'monthly' with step-line over 'linear'. RSI is ready to surge, ADXDI is fully charged. Stock is continuously creating higher highs and is expected to break the 600 mark by the end of the year.Longby UnknownUnicorn5323213Updated 3
$ISRG Impressive earnings For Intuitive Surgical.Looking for a possible long on a good break above $550. Shares of Intuitive Surgical (ISRG) jumped 3.9%, near 550, in after-hours trading on the stock market today. During the third quarter ended Sept. 30, Intuitive Surgical earned $3.43 per share, on an adjusted basis. Earnings increased more than 21% year over year and topped the average estimate of analysts polled by Zacks Investment Research for $2.96 a share. Revenue grew 23% to $1.13 billion and beat analyst forecasts for $1.06 billion. Procedures using Intuitive Surgical's biggest robotic surgery system, da Vinci, ramped up 20% year over year. Evercore ISI analyst Vijay Kumar called the number "impressive." Source Investor bus Daily. Company profile Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.Longby RedHotStocks17
Intuitive Surgical heading to ATH.ISRG surgical system enables minimally-invasive surgery, and decreases costs greatly in a industry where Surgical staffing issues are a problem throughout the world. The growth potential for ISRG expands as technology develops for remote medical treatments. There will come the day when many operations will be performed by AI powered robotics. Analysts average price target $583 | Overweight P/e ratio 55 Company profile Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.Longby Bullishcharts17
ISRG Short/ Put SpreadISRG Put Spread EXP October 18th. 505/465 Put Spread $13.93 Max Loss 40 point spread Target is $1300 Profit Max loss is $750 Market is trending lower, RSI is showing divergence and this is market wide ISRG is showing a rounding topping pattern which may move toward further support at 460 which will be my exit. Exit 1 = $460 underlying price while trying to get as close as possible to $1300 with a 10% tolerance plus or minus. Exit 2 = Market reversed and I take a $750 loss. It's possible my time target could be too far out and I may hit my target early if the market sells off leading into September.Shortby Synaptic7242
three drives you're outCheckout this repeating pattern... one bounce followed by an exhaustive three drives-ish pattern. Today was the third time it's gotten rejected from the .618 retrace, now at top of channel and showing momentum divergence. Bollinger showing it's coiled and ready for a move.Shortby chinawildmanUpdated 444
INTUITIVE SURGICAL (ISRG)Health Care/ Health Care Equipment Company announced 2Q earnings last week which exceeded expectations -it managed to increase gross margin by eliminating distributors and sell more directly. In 2019 Expected revenue +16.5%, EPS + 14.3%, EBITDA margin +3.4 p.p. (38.5%) In 2020 Expected revenue +23.1%, EPS + 13.7%, EBITDA margin -0.5 p.p. (38.0%) 12M Tgt Px is USD 571.88 (Bloomberg). Since last Friday analyst increased Target Px above USD 600 Company doesn't pay dividend. We are looking to enter long position at current levels - 2.0% portfolio exposure.by market-shepherd1